TABLE 9.
Impact of vitamin A/zinc supplementation while controlling for demographics and patients’ factors.
| Predictors | Estimates | 95% CI | p value |
|---|---|---|---|
| Age category | |||
| Infant | References | ||
| Toddler | −0.01 | −2.72–2.71 | 1.00 |
| Preschool | 1.06 | −1.81–3.93 | 0.46 |
| Gender | |||
| Female | References | ||
| Male | 0.27 | −1.25–1.78 | 0.73 |
| Weight CDC/WHO category | |||
| Healthy | References | ||
| Obese | 0.08 | −1.65–1.81 | 0.93 |
| Overweight | 0.57 | −1.78–2.92 | 0.63 |
| Underweight | 0.66 | −2.38–3.71 | 0.67 |
| Pneumonia grade | |||
| Grade 3 | References | ||
| Grade 4 | 3.16 | 1.41–4.90 | <0.01 |
| Effusion | |||
| Absent | References | ||
| Present | 3.89 | 1.68–6.11 | <0.01 |
| Treatment | |||
| Control | References | ||
| Vitamin A | −2.43 | −4.29–-0.57 | 0.01 |
| Zinc | −3.21 | −5.01–-1.41 | <0.01 |
R2/R2 adjusted 0.586/0.521. CI, confidence interval; CDC, Center of Disease Control and Prevention; WHO, World Health Organization.